Long-term fingolimod treatment may lessen disability Published: 27 May 2020 Long-term treatment with fingolimod results in lesser disability in people with relapsing remitting multiple sclerosis (MS), a new study has found.  People treated with the drug for eight or more years had smaller increases in disability over the course of